Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes (Q46105858)

19 December 2017

title

Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes (English)

1 reference

19 December 2017

1 reference

8

Joseph L Witztum

1 reference

19 December 2017

1

Sotirios Tsimikas

1 reference

19 December 2017

Jennifer Pattison

5

object named as

Jennifer Pattison

1 reference

19 December 2017

Claes Bergmark

2

object named as

Claes Bergmark

1 reference

19 December 2017

author name string

Reinaldo W Beyer

3

1 reference

19 December 2017

Raj Patel

4

1 reference

19 December 2017

Elizabeth Miller

6

1 reference

19 December 2017

Joseph Juliano

7

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

19 December 2017

Journal of the American College of Cardiology

published in

1 reference

19 December 2017

volume

41

1 reference

19 December 2017

issue

3

1 reference

19 December 2017

page(s)

360-370

1 reference

19 December 2017

The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

The oxidative modification hypothesis of atherosclerosis: does it hold for humans?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

Immune mechanisms in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

Autoantibodies to OxLDL are decreased in individuals with borderline hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol condensation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

Antibodies to oxidized LDL in relation to intima-media thickness in carotid and femoral arteries in 58-year-old subjectively clinically healthy men.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

Evidence for a role of phospholipid oxidation products in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

Anticardiolipin antibodies from patients with the antiphospholipid antibody syndrome recognize epitopes in both beta(2)-glycoprotein 1 and oxidized low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

Multiple Complex Coronary Plaques in Patients with Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

Malondialdehyde-modified LDL as a marker of acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

Lipoprotein(a): intrigues and insights

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

The immediate effect of streptokinase on serum lipoprotein(a) concentration and the effect of myocardial infarction on serum lipoprotein(a), apolipoproteins A1 and B, lipids and C-reactive protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

Enhanced association of platelet-activating factor acetylhydrolase with lipoprotein (a) in comparison with low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902769-9

7 January 2021

10.1016/S0735-1097(02)02769-9

Identifiers

DOI

1 reference

19 December 2017

PubMed ID

12575961

1 reference

19 December 2017